PALATINE, Ill., Oct. 10, 2008 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (Nasdaq:ACUR) announced that Robert Jones, Chief Operating Officer, will present at the Natixis Bleichroeder Hidden Gems Conference on Monday, October 13th at 3:00 p.m. ET at the Waldorf Astoria in New York City.
A live audio webcast of the presentation will be available at http://www.wsw.com/webcast/nblr2/acur/. A replay of the webcast may be accessed for 30 days at the same website.
About Acura Pharmaceuticals, Inc.
Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) (abuse deterrent) Technology and related product candidates. For more information, please visit www.acurapharm.com.
The Acura Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4847